SCHEMBL6507883

SCHEMBL6507883

CCCN[C@@H](CC(C)C)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
PLA2G2A P14555 2/20 0.36
PLA2G5 P39877 2/20 0.36
HPGDS O60760 2/20 0.35
CNR2 P34972 2/20 0.35
SLC7A5 Q01650 1/20 0.34
MAPT P10636 1/20 0.34
LAP3 P28838 3/20 0.34
ANPEP P15144 2/20 0.33
RNPEP Q9H4A4 2/20 0.33
DNPEP Q9ULA0 1/20 0.33
MMP8 P22894 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13374712 0.89 BCHE (0.50) BCHECA12CA1CA9ALDH1A1
SCHEMBL6035952 0.89 BCHE (0.50) BCHECA12CA1CA9ALDH1A1
SCHEMBL27696190 0.89 BCHE (0.50) BCHECA12CA1CA9ALDH1A1
SCHEMBL28089034 0.87 BCHE (0.46) BCHECA12CA1CA9PLA2G2A
SCHEMBL28089035 0.87 BCHE (0.46) BCHECA12CA1CA9PLA2G2A
SCHEMBL18944050 0.85 MMP8 (0.46) BCHEPLA2G2APLA2G5MMP8
SCHEMBL10454099 0.85 MMP8 (0.46) BCHEPLA2G2APLA2G5MMP8
SCHEMBL18944204 0.85 MMP8 (0.46) BCHEPLA2G2APLA2G5MMP8
SCHEMBL6036734 0.85 MMP8 (0.46) BCHEPLA2G2APLA2G5MMP8
Hydrochloric Acid SCHEMBL7765619 0.84 MMP8 (0.45) BCHEPLA2G2APLA2G5MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed